BN82002 is primarily utilized in the field of biomedical research, particularly in the study of cellular signaling pathways, including apoptosis. It is known for its role as a selective, cell-permeable, reversible inhibitor of caspase-3, which makes it valuable in understanding the mechanisms of certain enzymes and receptors involved in disease processes such as neurodegeneration and cell death. Researchers often employ this compound to investigate its effects on specific molecular targets, which can provide insights into potential therapeutic strategies for conditions such as cancer, inflammatory diseases, and neurological disorders like Alzheimer's and Parkinson's. Additionally, BN82002 is used in preclinical studies to evaluate its efficacy and safety profile, contributing to the development of novel drugs. Its application extends to in vitro and in vivo experiments, where it helps elucidate complex biological interactions and validate hypotheses related to cellular function and disease progression.